The chart below identifies updates for Pharmacy Medical Necessity Guidelines. For additional details and to access the guidelines referenced below, please visit the Pharmacy Medical Necessity Guidelines page on our Point32Health provider website.

Drug status changes
DrugPlanEff. DatePolicy and Additional Information
Empagliflozin Containing Sodium-Glucose Co-Transporter 2 (SGLT2) InhibitorsHarvard Pilgrim Commercial, Tufts Health Plan Commercial11/15/2026

New non-formulary prior authorization policy. 

For further details, please refer to this article.